Benzinga | Nov 5, 2020 05:58PM EST

Cellectis Q3 EPS $(0.63) Misses $(0.61) Estimate, Sales $10.21M Miss $10.79M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.61) by 3.28 percent. This is a 65.79 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $10.21 million which missed the analyst consensus estimate of $10.79 million by 5.41 percent. This is the same as the same period last year.